Embassy Suites and Hilton Franchise Holding to Face New York Class over Unpaid Gratuity

The judge noted that the employers failed to include information required by New York Wage Theft Prevention Laws: “The statements failed to provide the employer’s phone number… did not even identify the name of the employer… simply provided ‘Embassy Suites’ as the employer’s name without naming the actual individual or legal name of the company”.

Cryptocurrency Exchange Founders to Pay $10 Million Fine, Plead Guilty to Crimes

The US Attorney’s Office for the Southern District of New York released a statement that two founders of BitMEX would plead guilty to violating the Bank Secrecy Act (BSA) and failing to maintain anti-money laundering programs at their BitMEX cryptocurrency exchange.  The founders agreed to pay a $10 million fine.

Federal Judge Allows Criminal Charges For No-Poach Wage Fixing

The DOJ and state Attorneys General have become more active in investigating and enforcing action against companies who illegally agree to not poach employees from each other. When competitors in a market seek to collude, whether on prices paid by customers or prices they pay for labor, both federal and state antitrust laws can be violated.

Schneider Wallace Represents Therapists in Potential Class Action for Unpaid Overtime 

Schneider Wallace is representing two occupational and physical therapists in their potential class action against Cantex Continuing Care Network, for allegations of unpaid forced overtime. Cantex Continuing Care is headquartered in Texas with skilled nursing facilities, rehabilitation, home health, hospice and assisted living facilities in Texas, Louisiana and New Mexico. 

NY Nurses Request Class Certification For Unpaid Work During Breaks

Over 1,200 nurses represented by Schneider Wallace Cottrell Konecky requested a federal judge grant class certification to their allegations of unpaid wages at Arnot Health New York hospitals. The nurses claim automatic deductions for breaks occurred even as they worked through meals and breaks.

Schneider Wallace Cottrell Konecky Opens Los Angeles Office, Adds Four Partners

Schneider Wallace Cottrell Konecky LLP, a national plaintiff side law firm, is pleased to announce the March 14, 2022 opening of its new office in Los Angeles, California. The firm’s new office – its second in California and fifth nationwide – will focus on complex litigation involving employment, consumer protection, and antitrust matters. The Los Angeles office, located on 300 S. Grand Avenue, is within walking distance to both state and federal courthouses.

Blue Cross and Blue Shield of Minnesota Discloses Terms of Daraprim Antitrust Settlement

On February 10, 2022, the U.S. District Court for the Southern District of New York preliminarily approved a class settlement between Blue Cross and Blue Shield of Minnesota, on behalf of a putative class of health care payors, and Vyera and two of its executives, including Martin Shkreli, over their alleged anticompetitive conduct to protect exorbitant price increases for Daraprim.

BlockFi Agrees to $100 Million Settlement with SEC and 32 States for Unregistered Crypto Loans

On February 14th, 2022, the Security and Exchange Commission (SEC) revealed BlockFi had agreed to a $100 million settlement for failing to register their crypto lending products and for violations of the Investment Company Act of 1940 and Securities Act of 1933.

Preliminarily Approval of Teva $420 Million Generic Drug Price Fixing Settlement

On January 27, 2022, the U.S. District Court for the District of Connecticut gave preliminary approval to a $420 million all-cash deal to settle claims from a class of investors over misrepresentations related to the value of Teva’s generics drug business, which has been the subject of numerous investigations and lawsuits over far-reaching market allocation and price fixing practices.

Martin Shkreli Banned From Pharmaceutical Industry, Ordered to Pay $64.6 Million Over Daraprim

On January 14, 2022, United States District Court Judge Denise Cote ordered Martin Shkreli to pay a total of $64.6 million to seven states defrauded by Shkreli’s pharmaceutical company, Vyera, through its illegal pricing scheme for the drug Daraprim.  These states include New York, California, Ohio, Pennsylvania, Illinois, North Carolina and Virginia.  Judge Cote further ordered an injunction forever banning Shkreli from participating “in any capacity” in the pharmaceutical industry.